Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $12.6050 (-2.55%) ($12.6050 - $12.6050) on Tue. Aug. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.19% (three month average) | RSI | 38 | Latest Price | $12.6050(-2.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(46%) ARKK(45%) IBB(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.595% in a week (0% probabilities). VIXM(-37%) VXX(-27%) UNG(-12%) TLT(-10%) UUP(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.595% (StdDev 3.19%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
Resistance Level | $13.29 | 5 Day Moving Average | $12.91(-2.36%) | 10 Day Moving Average | $12.88(-2.14%) | 20 Day Moving Average | $13.29(-5.15%) | To recent high | -23.9% | To recent low | 0.3% | Market Cap | $937m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |